MYM Nutraceuticals Inc, (CSE: MYM) (OTCBB: MYMMF), a Canada-based company focused on the global growth of Cannabis and CBD-rich hemp, has named its current executives, Mark Forster and Paul Cheetham, as CFO and COO respectively of MYM International Brands Inc, it is reported today.
Both executives have transferred from MYM Nutraceuticals to the International Brands team to launch global expansion efforts of CBD-rich consumer products in a wide variety of categories, including food and beverage, pharmaceuticals, cosmetics, and health and wellness.
The company has also requested one of its present independent directors, Andrew Kent, to offer assistance by serving on the board of International Brands as an independent director, and accordingly he will step down as an independent director of the company while in that new capacity.
WuXi AppTec named to FTSE4Good Index Series for fourth consecutive year
Kibow Biotech receives AANP Corporation of the Year Award
EDX Medical to provide molecular profiling services to Astron Health
Futura Medical appoints Market Performance Group as new US distribution partner for Eroxon
MaaT Pharma to seek review after CHMP negative opinion on MaaT013 application
Sensei Biotherapeutics changes name to Faeth Therapeutics
Datavault AI and Wellgistics Health plan DelivMeds AI healthcare venture
Intensity Therapeutics receives Cancer Treatment Technology Innovator of the Year award
Solvonis Therapeutics appoints Water Tower Research to strengthen US market positioning